Richard B Melzer, MD in Billings, MT - Physician Assistant

Richard B Melzer, MD is a Physician Assistant - Medical physician based in Billings, Montana. Richard B Melzer is licensed to practice in Montana (license number 5160) and his current practice location is 801 N 29th St, Billings, Montana. He can be reached at his office (for appointments etc.) via phone at (406) 238-2500.

NPI number for Richard B Melzer is 1407953086 and his current mailing address is Po Box 35100, Billings, Montana. He does not participate in medicare program and thus does not accept medicare assignments. His NPI Number is 1407953086.

Contact Information

	Richard B Melzer, MD
	801 N 29th St, Billings, MT 59101-0905
	(406) 238-2500
	Not Available

Physician's Profile

Full Name	Richard B Melzer
Gender	Male
Speciality	Physician Assistant - Medical
Location	801 N 29th St, Billings, Montana
Accepts Medicare Assignments	Does not participate in Medicare Program. He may not accept medicare assignment.

NPI Data:

NPI Number: 1407953086
Provider Enumeration Date: 09/17/2006
Last Update Date: 12/09/2014

Medical Identifiers

Medical identifiers for Richard B Melzer such as npi, medicare ID, medicare PIN, medicaid, etc.

Identifier	Type	State	Issuer
1407953086	NPI	-	NPPES
000091270	Other	MT	BCBS PIN
0011220	Other	MT	MDCD PIN
314479	Other	WY	BCBS PIN
104547400	Other	WY	MDCD PIN

Medical Taxonomies and Licenses

Taxonomy	Type	License (State)	Status
208800000X	Urology	5160 (Montana)	Secondary
363AM0700X	Physician Assistant - Medical	5160 (Montana)	Primary

Medicare Part D Prescriber Enrollment

Any physician or other eligible professional who prescribes Part D drugs must either enroll in the Medicare program or opt out in order to prescribe drugs to their patients with Part D prescription drug benefit plans. Richard B Melzer is NOT enrolled with medicare and thus cannot prescribe medicare part D drugs to patients with medicare part D benefits.

Mailing Address and Practice Location

Mailing Address	Practice Location Address
Richard B Melzer, MD Po Box 35100, Billings, MT 59107-5100 Ph: (406) 238-2500	Richard B Melzer, MD 801 N 29th St, Billings, MT 59101-0905 Ph: (406) 238-2500

News Archive

NKI, Agendia and MD Anderson collaborate for colorectal cancer research

Agendia, a commercial-stage molecular cancer diagnostics company, announces today that it has entered into a research collaboration with The University of Texas MD Anderson Cancer Center, one of the world's leading cancer centers and whose research program is considered one of the most productive in the world aimed solely at cancer, and the Netherlands Cancer Institute (NKI) with the aim of improving diagnosis and treatment options of colorectal cancer patients.

FDA expands approval of cystic fibrosis treatment to include pediatric patients as young as 6 years old

The U.S. Food and Drug Administration today expanded the indication for Symdeko (a combination of tezacaftor/ivacaftor) tablets for treatment of pediatric patients ages 6 years and older with cystic fibrosis who have certain genetic mutations.

HCRI, MAHVI present transcatheter aortic valve data in severe stenosis at ACC meeting

The Harvard Clinical Research Institute and Saint Luke's Mid America Heart and Vascular Institute today announced that Matthew R. Reynolds, M.D., Director of the Economics and Quality of Life Research Center at HCRI, presented results of a cost-effectiveness analysis of transcatheter aortic valve replacement versus standard therapy for severe aortic stenosis, as part of the opening plenary session on April 3 at the American College of Cardiology 60th Annual Scientific Session & Expo.

New findings may help develop potential therapies for lupus, rheumatoid arthritis and cancer

Medical Research Council (MRC) scientists at the University of Leicester have made a new advance in understanding how the body fights certain types of cancer and other disease such as Lupus and rheumatoid arthritis.

Research highlights benefits from enhanced recovery after surgery program

Colorectal and bariatric surgery patients benefited from an enhanced recovery after surgery program, leaving the hospital sooner and requiring fewer opioids to control pain, according to new research presented at the American Society of Anesthesiologists PRACTICE MANAGEMENT 2018 meeting.

Richard B Melzer, MD - Physician Assistant in Billings, MT